Treatment of Recurrent Clostridium difficile Infection in an Immunocompromised Patient with Severe Neutropenia Not Responding to Standard Therapy
One of the most effective strategies in reducing the risk of Clostridium difficile infection (CDI) recurrence is fecal microbiota transplantation (FMT). However, several adverse events have been reported post FMT, and data on the efficacy and safety of FMT in immunocompromised patients with hematolo...
Saved in:
| Main Authors: | Hajar AlQahtani, Saeed Baloch, Deanne Tabb |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2020/3089023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tea and Recurrent Clostridium difficile Infection
by: Martin Oman Evans II, et al.
Published: (2016-01-01) -
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
by: Oluwaseun Shogbesan, et al.
Published: (2018-01-01) -
An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.
by: Natalia Blanco, et al.
Published: (2017-01-01) -
Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection
by: Natasa Popovic, et al.
Published: (2015-10-01) -
Guidelines for Clostridium difficile infection in adults
by: Michał Kukla, et al.
Published: (2020-03-01)